As of Q2'2023, is Pfizer spinning off any large business segments?
We expect to incur costs of approximately $700 million in connection with separating Upjohn, of which approximately 90% has been incurred since inception
and through the second quarter of 2023. These charges include costs and expenses related to separation of legal entities and transaction costs.
Yes, it's spinning off Upjohn.